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Abstract 
Transcription of the human c-erbB-2-proto-oncogene starts mainly at two sites, nucleotide positions +l and -69. The present studies have identified 
an initiator-like element hat specifies the position of transcription initiation at position -69. This initiator-like element contains six GGA repeats 
and is located just downstream from the transcription start site between positions -68 and -45. In addition, both in vitro and in vivo studies indicated 
that transcription initiation at position +1 is specified by a TATA box 25 bp upstream from the transcription startpoint. Thus, initiation at two sites 
in the c-erbB-2 promoter is controlled independently by the initiator-like element and the TATA box. 
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1. Introduction 
The transcription of eukaryotic genes by RNA polym- 
erase II is regulated through two types of DNA elements: 
core promoter elements at or near the transcriptional 
start site and regulatory elements in more distal pro- 
moter or enhancer regions (reviewed in [33]). A variety 
of sequence-specific a tivators or repressors interact with 
enhancers (reviewed in [28,34]), while essentially general 
initiation factors bind to core promoters (reviewed in 
[33,44]). Studies on various class II promoters indicate 
that they can be divided into several classes - those con- 
taining TATA elements, those containing initiator ele- 
ments, those containing both elements, and the remain- 
ing promoters, which have neither TATA nor common 
recognizable initiator elements. In the TATA-containing 
promoters, transcription usually starts about 30 bp 
downstream of the TATA box, and deletion of the 
TATA box can result in spurious initiations and a low 
level of transcription [16,17,18,44,57]. A TATA element 
is recognized by TATA box-binding factor TFIID 
WWI, which is a multisubunit protein complex 
[12,30,53,54,64], and the resulting complex provides the 
recognition signal for association of RNA polymerase II 
and the other general transcription factors [5,10, 
14,24,36,55]. Pyrimidine-rich initiator elements which 
overlaps or are close to transcription start sites were 
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identified in various promoters such as H2A histone [ 161, 
terminal deoxynucleotidyl transferase (TdT) [51], and 
adenovirus major late (AdML) [52] promoters. A se- 
quence is not strictly conserved in many of the known 
initiator elements, and the distribution and diversity of 
initiator-like elements among various promoters is not 
yet clear [4,19,37,39,51,52]; (reviewed in [59]). The initia- 
tor element is sufficient to direct accurate transcription 
initiation in the TATA-less promoters [51]. A 120-kDa 
protein termed TFII-I was recently demonstrated to bind 
to the initiator element of the AdML promoter, to direct 
the general transcription machinery at its binding site 
[42]. In addition, the initiator of the Ad2 IVa2 promoter 
is recognized by the YY 1 protein (also termed 6, NF-El 
or UCRBP) (for review, see [59]), which is required for 
efficient transcription in vitro [46,48]. In a group of pro- 
moters, both the TATA and initiator elements are lo- 
cated together and act in concert with each other. For 
example, both elements are required for efficient tran- 
scription from the s;fa promoter, and the partially puri- 
fied TFIID appears to contain a factor(s) that interacts 
with the initiator region in the s;fa promoter [38]. How- 
ever, the role of each element in the promoter containing 
both the TATA and initiator elements may vary among 
various promoters. In fact, TATA and the TdT initiator 
appeared to act independently of each other in the artifi- 
cially constructed promoter [39]. To understand the role 
of each element, the analysis of the role of TATA and 
initiator elements in various promoters containing both 
elements are required. 
The c-erbB-2 (HER-2) proto-oncogene [9,45] is the 
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human homolog of the rat neu gene [47] and encodes a 
185-kDa glycoprotein that is related to, but distinct 
from, the epidermal growth factor receptor [3,62]. The 
c-erbB-2 gene product has a tyrosine kinase activity [l]. 
Recently, a 44-kDa protein termed Neu differentiation 
factor (NDF) or heregulin that stimulates the kinase 
activity of the neulc-erbB-2 gene product was isolated 
[23,40]. However, whether NDF directly interacts with 
the c-erbB-2 gene product or interacts with a closely 
related receptor or with a heterodimer of c-erbB-2 pro- 
tein and related molecule still remains uncertain [41]. 
Amplification and overexpression of the c-erbB-2 gene 
were frequently detected in human adenocarcinomas, es- 
pecially in breast and stomach cancers [2,29,45,55,63]. 
Patients having breast cancers with amplification of the 
c-erbB-2 gene have a shorter time to relapse as well as 
a shorter overall survival [49,50]. These results suggest 
that a high level of c-erbB-2 expression contributes to 
tumor progression. In some human mammary tumor cell 
lines, an enhanced c-erbB-2 expression can occur in the 
absence of gene amplification, suggesting that a different 
molecular mechanism other than a gene amplification 
result in overexpression of the c-erbB-2 mRNA in some 
types of tumor cells [31]. As a first step to understand the 
transcriptional control of the human c-erbB-2 proto-on- 
cogene, we had identified and characterized the c-erbB-2 
promoter region [26]. The c-erbB-2 promoter initiates 
transcription mainly at two tightly clustered start sites, 
nucleotides +I and -69. Since the c-erbB-2 promoter 
contains a TATA element at -25, the transcription initi- 
ation at +l appears to be directed by a TATA element. 
However, the mechanism of the transcription initiation 
at -69 is not understood. 
Here, we show that the sequence, which is located 
downstream of the RNA start site at -69, is an initiator- 
like element for the transcription initiation at -69. Inter- 
estingly, the initiator-like element and the TATA element 
independently direct transcription initiation at -69 and 
+ 1, respectively, in the c-erbB-2 promoter. 
2. Materials and methods 
2.1. Construction of plasmids 
The plasmid pEBCAT4, in which the 250-bp &I-Sam1 (nucleotides 
-213 to +39) containing the human c-erbB-2 promoter is linked to the 
chloramphenicol acetyltransferase (CAT) gene, was described previ- 
ously [26]. To construct the pEBCAT4AInr, pEBCAT4ATATA: and 
pEBCAT4A+2/+10 mutants. a deletion was introduced bv the ~olvm- 
erase chain reaction @‘CR) method [22] as follows. The &ndIiI frag- 
ment of pEBCAT4 which contains the c-erbB-2 promoter was cloned 
into pUCl2. The generated plasmid pUCEB4 was used as a target 
DNA for PCR. Six oligonucleotides that contain sequences on either 
side of the region to be deleted were synthesized. They are 5’- 
C’ITGCTCCCAATCACA-GGGCT GCTTGAGGAAG-3’ (AInr), 
the sequence complementary to AInr (AInr-R), Y-GGGCTGCTT~ 
GAGGAAG---GAATGAAGTTGTGAAG-3’ (ATATA). the seauence 
complementary to ATATA (ATATA-R), \ Y-ITGTGAAGCT- 
GACATT---TGGGACCGGAGAAACC-3’ (A+U+lO), and the se- 
quence complementary to A+2/+10 (A+2/+10-R). Two oligonucleotides 
(M4 and RV) that contain sequences of the region outside of the cloning 
sites of pUCl2 were obtained from Takara Shuzo Co. Ltd. To intro- 
duce the deletion of the initiator-like sequence around -69 (AInr), two 
PCRs were first done separately with primers AInr and RV or AInr-R 
and M4. The products are separated from excess primers, and mixed, 
denatured, and allowed to reanneal. Some of the molecules recombine 
through the overlap made by the primers AInr and AInr-R. By using 
these reannealed DNAs as a target, PCR was done with the outside 
primers M4 and RV. The amplified DNA was digested with Hind111 
and cloned into pSVOCAT. The generated clone was confirmed to 
contain the deletion of the initiator-like sequence around -69 by DNA 
sequencing. The deletion of the TATA element (mATA) or the initia- 
tor-like sequence around +1 (A+ 2/+ 10) was also introduced in a sim- 
ilar way. 
2.2. DNA transfection and RNA analysis 
Mixtures of 6 pg of each CAT pla&id DNA, 6 pg of pUCl9 DNA, 
and 2 ua of pRSV-/Y-gal Dlasmid DNA 1131 were transfected into CV-1 
cells by fhe CaPQ’method as described-[1 51. The plasmid pRSV;B-gal, 
which carries the E. coli /I-galactosidase gene linked to the LTR pro- 
moter of Rous sarcoma virus, was used as an internal control for 
differences in transfection efficiency between precipitates. To analyze 
CAT RNA, RNA was isolated by the guanidium thiocyanate method 
[7] 40 h after transfection. At the same time/?-galactosidase activity was 
measured using a sample of cells to contirm that transfection efficien- 
cies were similar. Primer extension analysis was done as described by 
Muhich et al. 1351 with 50 UP of ~olv(A)’ RNA. A svnthetic 24base 
oligonucleotidd (s’-GCCA~GG&4TATATCAACGGTGG-3’) com- 
plementary to nucleotides 26-49 of the coding sequence of the CAT 
gene was used as a primer. The amount of the extended primer was 
measured by a Bioimage Analyzer (Fuji Photo Film Co. Ltd.). 
2.3. DNase Ifootprint analyses with human TFIID 
The HindIII-HaeII fragment (nucleotides +39 to -192) of pEBCAT1 
[26], in which the 530-bp DNA fragment containing the c-erbB-2 pro- 
moter was linked to the CAT gene, was j2P-labeled at the 5’-end of the 
Hind111 site with T4 polynucleotide kinase. The binding reaction was 
done by using approximately 5ng of “P-labeled DNA fragment in 25 ,ul 
reaction mixture containing 12 mM Tris-HCl (pH 7.7 at 4”C), 40 mM 
HEPES (pH 8.4), 60 mM KCl, 12% (v/v) glycerol, 4 mM MgCIZ, 2&ml 
poly(dG-dC), 0.1 mg/ml bovine serum albumin, and 0.6 pg of human 
TFIID (w-amino octyl agarose fraction) [35,36]. The DNase I digestion 
was done with 5 &ml DNase I for 30 s at 30°C and then stopped by 
the addition of 75 ~1 of a solution containing 12 mM EDTA and 4b 
&ml of tRNA. The DNA was extracted bv DhenoUchloroform fol- 
lowed by ethanol precipitation, and then analyzed on an 8% sequencing 
gel. 
2.4. In vitro transcription 
HeLa cells nuclear extract was prepared essentially as described by 
Dignam et al. [1 11. Heat-treated nuclear extract was prepared as de- 
scribed by Nakajima et al. [36]. Fifteen pl of HeLa nuclear extract was 
incubated with 0.5 pg of supercoiled template DNA in 25 pl of reaction 
containing 12 mM Tris-HCl (PH 7.9), 20 mM HEPES (pH 8.4), 12% 
(v/v) glycerol, 60 mM KCl, 8 mM MgCl,, and 0.5 mM each of all four 
ribonucleoside triphosphate. Following the incubation at 30°C for 60 
min, transcription was stopped by adding 75 ~1 of solution containing 
450 mM sodium acetate (pH 5.2), 10 mM EDTA, 0.5% SDS, and 1 
mg/ml yeast tRNA to the reaction mixture. RNA was isolated by 
phenol/chloroform extraction followed by ethanol precipitation. 
Primer extension analysis was done as described above. 
3. Results 
3.1. The c-erbB-2 promoter has initiator-like sequences 
and a functional TATA element 
To begin the analysis of the mechanism by which tran- 
scription starts at two clustered sites (+l and -69) in the 
c-erbB-2 promoter, we compared the resident nucleotide 
sequence (Fig. la) with those of other promoters con- 
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Fig. 1. The initiator-like sequences in the human c-erbB-2 promoter. (a) Nucleotide sequence of the human c-erbb2 promoter region [26]. Nucleotide 
+ 1 corresponds to the farthest downstream RNA start site and residues preceding this position are represented by negative numbers. The two clustered 
RNA start sites are indicated by arrows. The TATA and CCAAT sequences are boxed, and the initiator-like sequences are underlined. (b) Similarity 
of the c-erbB-2 initiator-like sequence around -69 and the initiator sequences of other promoters. Arrows indicate the major transcription start sites. 
The GGA sequence is also shown by arrows. (c) Similarity of the c-erbb2 initiator-like sequence around +l and the pyrimidine-rich initiator 
sequences. 
taining the initiator elements. A strict sequence conserva- sequence, and contains three GGA repeats [37]. Some of 
tion was not observed between the sequence around -69 the known initiator elements, including that of the ribo- 
of the c-erbB-2 promoter and those of several known somal protein gene, have a pyrimidine-rich sequence [ 191, 
initiator elements. However, the sequence downstream and their complementary sequences are purine-rich (Fig. 
of -69 in the c-erbB-2 promoter is purine-rich and is lb). Therefore, if the orientations and the positions of the 
similar to the gfa downstream initiator-like element (Fig. initiator elements are not necessarily fixed, the purine- 
lb). This purine-rich sequence of the c-erbB-2 promoter rich sequence in the c-erbB-2 promoter are a good candi- 
consists of six GGA repeats, one GAA sequence, and date for an initiator. The c-erbB-2 promoter also has an 
one GGT sequence. The &fa initiator-like element hat is initiator-like sequence around the downstream transcrip- 
downstream of the RNA start site also has a purine-rich tion start site at nucleotide position +l (Fig. lc). The 
G. Mizuguchi et al. IFEBS Letters 348 (1994) 80-88 
sequence around +l in the c-erbB-2 promoter is 
ATTCCCT which matches the consensus sequence for 
the pyrimidine-rich initiator or initiator-like element 
identified in promoters such as TdT and AdML promot- 
ers [39], although the initiating base of the c-erbB-2 pro- 
moter (the second T residue) is different from those of 
other promoters (the A residue) in this consensus se- 
quence. Thus, two initiator-like sequences are located in 
the c-erbB-2 promoter, similar to situation described for 
several other promoters with single initiation site [39]. 
In addition to the initiator-like sequences, the c-erbB-2 
promoter also contains a TATA box which sequence is 
TATAA at -25. To examine whether TATA box-bind- 
ing factor TFIID can bind to this TATAA element, 
DNase I footprint analysis was done. The TFIID puri- 
fied from HeLa cells protected a region corresponding 
to nucleotides -18 to -31 which contains the TATAA 
sequence at the center (Fig. 2). Thus, the c-erbB-2 pro- 
moter contains both the initiator-like sequences and a 
possibly functional TATA element. 
3.2. Role of the initiator-like sequences and the TATA 
element in in vitro transcription 
To study the functional role of the initiator-like se- 
quences around -69 and +l and the TATA element at 
-25 in the c-erbB-2 promoter, and functional relation- 
ship between them, three promoter mutants lacking ei- 
ther of two initiator-like sequences (dInr or d+ 2/+ 10) 
or the TATA element (ATATA) were constructed (Fig. 
3). To examine the ability of the transcription initiation 
from the c-erbB-2 mutant promoters, we employed an in 
vitro transcription system derived from HeLa nuclear 
extract with the supercoiled CAT plasmid DNA contain- 
ing the wild-type promoter or a promoter having one of 
its elements deleted as templates (Fig. 4). The transcripts 
were detected by primer extension analysis with a primer 
of the synthetic oligonucleotide complementary to the 
coding sequence of the CAT gene (Fig. 4a and b). The 
193- and 124-base xtended primers correspond to the 
predicted length of c-erbB-2-CAT mRNA initiated from 
-69 and +l in the c-erbB-2 promoter, respectively (108 
or 39 nucleotides of c-erbB-2 mRNA plus 85 nucleotides 
of CAT RNA). The amount of each extended primer was 
measured and represented by a bar graph in Fig. 4c. A 
template containing the wild-type promoter generated 
transcripts corresponding to initiations at both -69 and 
+l, respectively, and the ratio of transcripts was about 
1: 1.4. In the following part of this paper, the amount of 
transcripts is shown relative to that started from -69 in 
pEBCAT4. From the hsp70-CAT control template, in 
which the 5’ regulatory region of the human hsp70 gene 
was linked to the CAT gene [61], the 235-base xtended 
primer was generated (150 nucleotides of hsp70 mRNA 
plus 85 nucleotides of CAT RNA). Deletion of the initi- 
ator-like sequence around -69 abolished the transcrip- 
tion initiation at -69, but not at +l . In the case of 
83 
Fig. 2. DNase I footprinting analysis of TFIID binding to the TATA 
element of the c-e&B-2 promoter. The HindIII-Hue11 fragment of the 
plasmid pEBCAT1 that spanned the c-erbB-2 promoter was “‘P-labeled 
at the 5’-end of the Hind111 site. The labeled DNA fragment was 
incubated with 0.6 pug of purified human TFIID (lanes 3 and 4) or no 
protein (lane 2). DNase I digestions were done with 3 (lanes 2 and 3) 
or 5 (lane 4) &ml DNase I. The position of the protected region is 
shown on the right. A + G (lane 1) refers to the adenine and guanine 
marker obtained by the chemical cleavage of the same end-labeled 
DNA fragment. 
dTATA, on the other hand, the transcription initiation 
at +l was not observed, but the amount of transcripts 
started from -69 was similar to that in the wild-type 
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promoter. Deletion of the initiator-like sequence around 
+ 1 affected neither the transcription initiation at -69 nor 
+l. Thus, the initiator-like sequence containing the 
GGA repeats region around -69 functions as an initia- 
tor-like element for the transcription initiation at -69, 
whereas the initiator-like sequence around +l does not. 
Furthermore, a TATA box at -25 controls the transcrip- 
tion initiation at + 1. These results indicate that the tran- 
scription initiations at -69 and +l are governed inde- 
pendently by the initiator-like element and the TATA 
element, respectively. 
the transcription initiation at + 1 whereas transcription 
initiation at -69 utilizes a heat resistant form of TFIID. 
3.4. Role of the initiator-like element and TATA element 
in the c-erbB-2 promoter in vivo 
3.3. TFIID is required for the transcription initiation 
at +I 
Mild heat treatment of a nuclear extract preferentially 
inactivates TFIID, and supplementation of the heat- 
treated extract with TFIID-containing fractions can re- 
store AdML promoter-dependent ranscription [36]. 
Using the human hsp70 promoter [61] as a control (the 
initiation of transcription driven by this promoter is de- 
pendent on its TATA element), we asked whether the 
transcription initiations at -69 and +I were TFIID de- 
pendent. Nuclear extracts were heated for 15 min at 
47°C and immediately used for in vitro transcription. As 
shown in Fig. 5, the transcription initiation at +I was 
completely abolished after this treatment whereas the 
transcription initiation at -69 was unaffected. Then, the 
purified human TFIID was added to the heat-treated 
extract and used for the in vitro transcription. Addition 
of TFIID completely restored the transcription initiation 
at +I. These results indicate that TFIID is required for 
To confirm the in vivo roles of the initiator-like ele- 
ment around -69 and the TATA element at -25, CV-1 
cells were transfected with the CAT plasmid containing 
the wild-type or mutant c-erbB-2 promoter, and RNAs 
were analyzed by primer extension analysis (Fig. 6). 
With the wild-type promoter, the level of transcripts 
started from +I was about 70% of that from -69. Dele- 
tion of the initiator-like element (dInr) markedly de- 
creased the amount of -69 transcripts, but did not affect 
the amount of +I transcripts. In contrast, deletion of the 
TATA element @TATA) almost completely abolished 
the transcription initiation at + 1, but had no effect on the 
transcription initiation at -69. These in vivo results are 
consistent with those obtained by the in vitro transcrip- 
tion studies. Thus, in both in vivo and in vitro transcrip- 
tion assays, the initiator-like element and the TATA ele- 
ment independently control the transcription initiations 
at -69 and +l, respectively. 
4. Discussion 
In spite of the presence of a typical TATA box, the 
human c-erbB-2 promoter has two RNA start sites, at 
positions +l and -69 [26]. Since the TATA element is 25 
bp upstream of the RNA start site +I, the transcription 
A Inr A TATA At2/tlO 
-70 
ml 
-40 
CA~A~AGAAG&AGGlXGA&A~~~ 
-20 
G AGGAAiG~AAi-GAAGl.T&~GCTGA~A 
CCAAT TATAA 
pEBCAT4 
AInr I+ dGb > TATAA 
pEBCAT4 M 
ATATA 
UXAT < 
pEECAT 
At2/+10 I+ 
CCAAT TATAA 
Fig. 3. Structure of the four c-erbB-2 promoter-CAT constructs used. The plasmid pEBCAT4 contains the wild-type c-erbB-2 promoter. The three 
constructs pEBCAT4dInr, pEBCAT4dTATA and pEBCAT4d+2/+ 10 are deletion mutants of the initiator-like sequence around -69, the TATA 
element, and the initiator-like sequence around +l, respectively. The nucleotide sequences deleted in three plasmids are indicated at the top. 
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Fig. 4. In vitro transcription of the c-e&B-2 promoter mutants. (a) A schematic representation of the primer extension analysis of CAT RNA. Primer 
extension analysis was done with a primer complementary to a segment of CAT mRNA. (b) In vitro transcription with various promoters. The closed 
circular DNA of the human hsp70 promoter-CAT plasmid (lane 1) or a mixture of the closed circular DNAs of the c-erbB-2 promoter-CAT construct 
shown above each lane and the hsp70 promoter-CAT plasmid (lanes 3-6) was transcribed in HeLa nuclear extracts. The human hsp70 promoter-CAT 
plasmid was used as the control template. The transcribed CAT RNAs were analyzed by primer extension analysis. The extended primers 
corresponding to the c-erbB-2-CAT mRNA started from -69 to +l, and that corresponding to the hsp70-CAT mRNA are shown by arrows. 
“P-Labeled H&I-digested pBR322 was used as a size marker (lane 1). (c) Quantitation of in vitro transcription with various promoters. The amount 
of extended primer generated from the c-erbB-2-CAT mRNA was measured, and is expressed relative to that corresponding to the c-erbB-2 CAT 
mRNA started from -69 in pEBCAT4. The open and shaded bars correspond to the transcripts tarted from -69 and + 1, respectively. The amount 
of each extended primer corresponding to the c-erbB-2-CAT mRNA was normalized with respect o that generated from the hsp7OCAT mRNA. 
initiation from this site was assumed to be directed by the and TATA elements. Initiation from a single site in pro- 
TATA element. In contrast, no mechanism of the tran- moters such as the AdML promoter and the gfa pro- 
scription initiation from -69 has been advanced. We moter appear to require or to be influenced by both the 
have identified the initiator-like element for the tran- TATA and initiator elements [20,37]. Furthermore, a 
scription initiation from -69, which has the features of combination of the initiator of the TdT gene with the 
the presence of GGA repeats and the location in down- TATA box of the AdML promoter produces a greatly 
stream from the RNA start site. The most interesting increased level of transcription initiation at the initiator 
property of the transcription from this c-erbB-2 pro- [51]. On the other hand, recently, a TATA element and 
moter is the completely independent control of transcrip- the TdT initiator in the artificially constructed promoter 
tion initiations from those two sites by the initiator-like were shown to act independently of each other [39]. 
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a b 
hsp70 
-69 
0 : -69 :+l 
Fig. 5. Requirement of TFIID for in vitro transcription initiation at +l in the c-erbB-2 promoter. (a) Recovery of transcription activity of heat-treated 
nuclear extract by adding TFIID. The closed circular DNA of hsp70 promoter-CAT construct (lane 2) or a mixture of the closed circular DNAs 
of pEBCAT4 and hsp70 promoter-CAT construct (lanes 3-5) was used as a DNA template for in vitro transcription. The human hsp70 promoter-CAT 
plasmid was used as the control template. In vitro transcription was done with HeLa nuclear extract (lanes 2 and 3), heat-treated HeLa nuclear extract 
(lane 4), or heat-treated HeLa nuclear extract complemented with the purified human TFIID (lane 5). Heat treatment of HeLa nuclear extract 
selectively inactivated the TFIID activity. The transcribed CAT RNAs were analyzed by primer extension analys as shown in Fig. 4a. The extended 
primers corresponding to the c-erbB-2-CAT mRNA started from -69 and +l, and that corresponding to the hsp70CAT mRNA are indicated by 
arrows. 32P-Labeled Hi&-digested pBR322 was used as a size marker (lane 1). (b) Quantitation of in vitro transcription. 
However, to our knowledge, our studies about the 
c-erbB-2 promoter provides the first evidence for the 
independent control of transcription initiation by two 
elements, a TATA box and an initiator-like element, in 
a natural promoter containing both elements. 
The sequence of the c-erbB-2 initiator-like element 
identified here is purine-rich and contains several GGA 
repeats. A similar purine-rich sequence was found in the 
sense strand of the gfa downstream initiator-like element 
[37] and in the opposite strand of the initiators or initia- 
tor-like elements found in promoters such as the TdT, 
AdML [51], and ribosomal protein gene promoters [19], 
but the presence of several GGA repeats is unique to the 
c-erbB-2 initiator-like element. Evidence reported so far 
for the initiator-like elements in the ribosomal protein 
gene (rpS16) promoters also confirm the difference be- 
tween these initiator-like elements and the c-erbB-2 initi- 
ator-like element. Mutagenesis analysis of the rpS16 
gene initiator-like element indicated that an uninter- 
rupted stretch of pyrimidines in the region containing 
this element is not necessary for efficient transcription 
[19]. Interestingly, several repeats of TCC, an inverted 
sequence of GGA, were found in several promoter re- 
gions including the EGF receptor gene [25] and the 
mouse c-myb gene [58], both of which have multiple 
RNA start sites. The region containing TCC repeats is 
known to bind nuclear proteins [27] and to be associated 
with Sl nuclease sensitivity [32]. If the binding of pro- 
teins to these sequences is independent of the DNA se- 
quence orientation, the TCC repeats also may function 
like the c-erbB-2 initiator-like element. 
The afa initiator-like element was protected from 
DNase digestion by HeLa TFIID, suggesting that par- 
tially purified human TFIID contains a component(s) 
that interacts with the afa initiator-like element [38]. In 
contrast, HeLa TFIID protected from DNase digestion 
only the TATA element not the initiator-like element in 
the c-erbB-2 promoter, in spite of the short distance be- 
tween the two elements. Consistent with this, we recently 
detected a protein in HeLa nuclear extract that binds to 
the c-erbB-2 initiator-like element by using gel retarda- 
tion analysis, and this protein was separated from the 
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Fig. 6. Role of the initiator-like and TATA elements on the c-erbB-2 promoter activity in vivo. (a) Primer extension analysis of CAT RNA. RNA 
was prepared from CV-1 cells transfected by a mixture of CAT plasmid DNA indicated above each lane and pRSV-/?-gal plasmid DNA. The CAT 
RNAs were analyzed by primer extension analysis as shown in Fig. 4a. The extended primers corresponding to the c-erbB-2-CAT mRNAs started 
from -69 and +1 in the c-erbB-2 promoter are indicated by arrows. 32P-Labeled Hi&digested pBR322 was used as a size marker (lane 1). 
(b) Quantitation of primer extension analysis. 
TFIID activity by chromatography on a phosphocellu- 
lose column (data not shown). These results strongly 
suggest that the protein which binds to the c-erbB-2 ini- 
tiator-like element is not associated with TFIID, unlike 
the protein which binds to the afa initiator-like element. 
Heat-inactivation of the TFIID activity suppressed the 
transcription initiation from position + 1, but not posi- 
tion -69 in the c-erbB-2 promoter. Transcription initia- 
tion in human porphobilinogen deaminase (PBGD) gene 
promoter, which lacks a TATA element but contains an 
initiator element around the initiation site, was also re- 
ported to be unaffected by heat-inactivation of the 
TFIID activity [4]. The TATA box-binding subunit 
(TBP or TFIIDr) involved in a TFIID complex plays a 
central role in transcription by RNA polymerase II. Fol- 
lowing two observations uggest that TBP is positioned 
in initiation complexes formed on both TATA-contain- 
ing and TATA-less promoters; TBP can bind with weak 
affinity to the -30 region of several TATA-less promot- 
ers including the TdT promoter [60], and in addition 
insertion of a TATA box upstream of an initiator aug- 
ments transcription efficiency [6,51]. The recent finding 
that TBP is an integral component of the RNA polym- 
erase I transcription factor, SLl [8] also may support the 
possibility that TBP is a universal eukaryotic transcrip- 
tion factor (for review, see [21]). Therefore, it is likely 
that a TBP-containing TFIID complex, which partici- 
pates in the transcription initiation mediated by a c-erbB- 
2 initiator-like element, involves some additional fac- 
tor(s) which confers heat resistance. 
By identification of a resident initiator-like element, 
the structure of the c-erbB-2 core promoter has been 
clarified. Since transcription initiation events from two 
sites are independently controlled by TATA element and 
initiator-like elements, it will be interesting to determine 
whether the ratio of transcripts initiated from +l and 
-69 is constant or variable in various cells. Furthermore, 
it will be important to address the contributions of the 
initiator and TATA elements towards mediating tran- 
scriptional activation by the activators such as the 
CAAT box-binding proteins that binds to the upstream 
region in the c-erbB-2 promoter. Further study of the 
c-erbB-2 initiator-like element and the protein(s) which 
binds to this element will help to understand not only the 
diversity of initiator but also the mechanism by which the 
expression of the c-erbB-2 proto-oncogene is regulated. 
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